BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27769870)

  • 21. The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center.
    Arroyo MR; Green DM; Perlman EJ; Beckwith JB; Argani P
    Am J Surg Pathol; 2001 Apr; 25(4):433-44. PubMed ID: 11257617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent metanephric stromal tumor in an infant.
    De Pasquale MD; Diomedi-Camassei F; Serra A; Boldrini R; Inserra A; Caione P; Jenkner A
    Urology; 2011 Dec; 78(6):1411-3. PubMed ID: 21683990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
    Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
    Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
    Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.
    Wegert J; Vokuhl C; Collord G; Del Castillo Velasco-Herrera M; Farndon SJ; Guzzo C; Jorgensen M; Anderson J; Slater O; Duncan C; Bausenwein S; Streitenberger H; Ziegler B; Furtwängler R; Graf N; Stratton MR; Campbell PJ; Jones DT; Koelsche C; Pfister SM; Mifsud W; Sebire N; Sparber-Sauer M; Koscielniak E; Rosenwald A; Gessler M; Behjati S
    Nat Commun; 2018 Jun; 9(1):2378. PubMed ID: 29915264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metanephric stromal tumor: a rare benign pediatric renal mass.
    Palese MA; Ferrer F; Perlman E; Gearhart JP
    Urology; 2001 Sep; 58(3):462. PubMed ID: 11549506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.
    Zhao M; Yin M; Kuick CH; Chen H; Aw SJ; Merchant K; Ng EHQ; Gunaratne S; Loh AHP; Gu W; Tang H; Chang KTE
    Histopathology; 2020 Oct; 77(4):611-621. PubMed ID: 32590884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer.
    Murugan AK; Qasem E; Al-Hindi H; Shi Y; Alzahrani AS
    J Transl Med; 2016 Jul; 14(1):204. PubMed ID: 27387551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hotspot mutations of BRAF gene are not associated with pediatric solid neoplasms.
    Miao J; Kusafuka T; Fukuzawa M
    Oncol Rep; 2004 Dec; 12(6):1269-72. PubMed ID: 15547749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
    Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
    Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?
    Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F
    Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.
    Kansal R; Quintanilla-Martinez L; Datta V; Lopategui J; Garshfield G; Nathwani BN
    Genes Chromosomes Cancer; 2013 Jan; 52(1):99-106. PubMed ID: 22996177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
    Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Ozer E; Sevinc A; Ince D; Yuzuguldu R; Olgun N
    Pediatr Dev Pathol; 2019 Oct; 22(5):449-455. PubMed ID: 31072207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry.
    Méhes G; Irsai G; Bedekovics J; Beke L; Fazakas F; Rózsa T; Kiss C
    Am J Surg Pathol; 2014 Dec; 38(12):1644-8. PubMed ID: 25118810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
    Behling F; Barrantes-Freer A; Skardelly M; Nieser M; Christians A; Stockhammer F; Rohde V; Tatagiba M; Hartmann C; Stadelmann C; Schittenhelm J
    Diagn Pathol; 2016 Jun; 11(1):55. PubMed ID: 27350555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
    Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
    Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
    Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT
    Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
    Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.